Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Neurogene Inc (NGNE)

Neurogene Inc (NGNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 454,300
  • Shares Outstanding, K 12,980
  • Annual Sales, $ 0 K
  • Annual Income, $ -36,320 K
  • 60-Month Beta 1.49
  • Price/Sales 491.76
  • Price/Cash Flow N/A
  • Price/Book 2.93
Trade NGNE with:

Options Overview Details

View History
  • Implied Volatility 65.26% ( +9.30%)
  • Historical Volatility 67.12%
  • IV Percentile 90%
  • IV Rank 100.00%
  • IV High 65.26% on 09/04/24
  • IV Low 55.96% on 08/26/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 2
  • Volume Avg (30-Day) 1
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 1
  • Open Int (30-Day) 0

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate -1.23
  • Number of Estimates 5
  • High Estimate -1.15
  • Low Estimate -1.34
  • Prior Year -1.64
  • Growth Rate Est. (year over year) +25.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
32.15 +9.27%
on 09/04/24
38.17 -7.96%
on 08/30/24
-0.46 (-1.29%)
since 08/09/24
3-Month
29.69 +18.32%
on 06/18/24
49.05 -28.38%
on 07/15/24
-2.75 (-7.26%)
since 06/07/24
52-Week
12.49 +181.27%
on 12/20/23
53.00 -33.72%
on 03/22/24
+19.13 (+119.56%)
since 09/08/23

Most Recent Stories

More News
Neurogene: Q2 Earnings Snapshot

Neurogene: Q2 Earnings Snapshot

NGNE : 35.13 (+0.37%)

Business Summary

Neurogene Inc. is a clinical-stage company which bring life-changing genetic medicines to patients and families affected by rare neurological diseases. Neurogene Inc., formerly known as Neoleukin Therapeutics Inc., is based in NEW YORK.

See More

Key Turning Points

3rd Resistance Point 41.34
2nd Resistance Point 39.64
1st Resistance Point 37.39
Last Price 35.13
1st Support Level 33.44
2nd Support Level 31.74
3rd Support Level 29.49

See More

52-Week High 53.00
Fibonacci 61.8% 37.53
Last Price 35.13
Fibonacci 50% 32.74
Fibonacci 38.2% 27.96
52-Week Low 12.49

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar